Novo Holdings Leads USD125m Series C for Singapore’s Hummingbird Bioscience

Novo Holdings led a USD125m Series C for Hummingbird Bioscience, a Singapore- and US-based clinical stage developer of targeted therapeutics, with participation from Frazier Healthcare Partners, Octagon Capital, EDBI, AMGEN Ventures, DROIA Ventures, Morningside Ventures, Pureos Bioventures, Polaris Partners, Affinity Asset Advisors, Ally Bridge Group and Altrium Capital Management, and… Read More

VIG Acquires South Korea’s The Skin Factory for USD132-177m

VIG Partners, through its VIG Partners Fund IV, has acquired 100% of South Korea-based home and personal care company The Skin Factory for KRW150-200b (~USD132-177m). According to AVCJ, the transaction includes an approximately KRW100b (~USD88m) equity commitment from VIG, plus debt financing and an LP co-investment. Read… Read More



(default archive template)